Skip to content

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma: A Randomized Prospective Double-blinded Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01744314
Enrollment
150
Registered
2012-12-06
Start date
2012-11-30
Completion date
2019-11-30
Last updated
2017-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Trauma Requiring Operative Management

Keywords

Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis

Brief summary

Patients who present to our institution with a traumatic injury to their elbow who need operative management will be randomized to one of two groups; a treatment arm and a control arm. The treatment arm will receive a three-week postoperative course of indomethacin while the control group will not. We will follow both groups to assess whether or not indomethacin prophylaxis affects the rate of heterotopic ossification.

Interventions

DRUGIndomethacin and Pantoprazole
DRUGmicrocrystalline cellulose powder tablets

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Terrible Triad * Radial head fracture surgical treatment * Monteggia and Trans-olecranon Fracture Dislocations * Distal Biceps Tendon Injuries * Distal Humerus Fractures * Coronoid Fractures * Capitellar-Trochlear fractures * Olecranon Fractures

Exclusion criteria

* Associated Traumatic Brain Injury * Burn Injuries associated with elbow trauma * History of Gastric Ulcers * Documented allergies to any Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) * Severe Asthma * Previous operative fixation to affected elbow * Participation in other research study * Inability to speak / understand English

Design outcomes

Primary

MeasureTime frameDescription
change in post operative radiographic evaluation6 weeks and 3, 6 and 12 mfupAS a standard care patients will be routinely assess at three, six , twelve and twenty four months post-operatively.

Secondary

MeasureTime frameDescription
change in range of motion6 weeks and 3, 6 and 12 mfupmeasuring range of motion with a goniometer will be performed at 6 weeks and 3, 6 and 12 mfup
Patient Rate Elbow Evaluation6 weeks and 3, 6 and 12 mfupis a 20-item questionnaire designed to measure elbow pain and disability
The Mayo Elbow Performance score6 weeks and 3, 6 and 12 mfupis an instrument used to test the limitations to use the elbow during ADL caused by the pathology
Disabilities of the Arm, Shoulder and Hand6 weeks and 3, 6 and 12 mfupis a 30-item, self-report questionnaire designed to measure physical function and symptoms in people with any of several musculoskeletal disorders of the upper limb.

Countries

Canada

Contacts

Primary ContactGeorge Athwal, MD
<gathwal@uwo.ca>519-646-6100
Backup ContactKate Kelly, MSc, MPH
Kate.Kelly@sjhc.london.on.ca519-646-6100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026